Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Gastrointestinal Stromal Tumors 6 Leukemia, Myeloid, Chronic-Phase 4 Leukemia 4 Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Sarcoma 1 Relapsed Pediatric Solid Tumor 1 Mesothelioma 1 Meningioma 1 Leukemia, Myeloid 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 GIST 1 Drug-Related Side Effects and Adverse Reactions 1 Chordoma 1 Central Nervous System Neoplasms 1 Carcinoma, Adenoid Cystic 1 Brain Neoplasms 1

Interventions

Imatinib Mesylate 1 Coal Tar 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × GIST × Imatinib Mesylate × Clear all

NCT05895942 2023-06-09

EMMBKM

Xijing Hospital

GIST

Data powered by HemOnc (CC BY 4.0) Colophon ⚡